Genscript Biotech (G51.STU) Q3 2026 Earnings

17AugConfirmed
Q1 2026
-0.2
-0.14
-0.08
-0.03

Details

Expected EPS
-0.008553100000000001
Actual EPS
N/A
Surprise EPS
0.01
Surprise Percent
+100%

Description

Genscript Biotech (G51.STU) will report earnings of for Q3 2026 on August 17, 2026.

0 Comments

Share your thoughts